Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study
- Author
- ORLAND, J. R1 2 ; ENGSTROM, J1 ; LOUGHLIN, K9 ; MURPHY, E. L1 2 ; FRIDEY, J3 ; SACHER, R. A4 ; SMITH, J. W5 ; NASS, C6 ; GARRATTY, G7 ; NEWMAN, B8 ; SMITH, D9 ; WANG, B9
[1] University of California San Francisco, San Francisco, United States
[2] Blood Centers of the Pacific, San Francisco, United States
[3] City of Hope National Medical Center, Duarte, CA, United States
[4] Hoxworth Blood Center and University of Cincinnati, OH, United States
[5] Oklahoma Blood Institute, Oklahoma City, United States
[6] American Red Cross Blood Services, Chesapeake Region, Baltimore, MD, United States
[7] American Red Cross Blood Services, Southern California Region, Los Angeles, United States
[8] American Red Cross Blood Services, Southeastern Michigan Region, Detroit, United States
[9] Westat, Rockville, MD, United States - Source
Neurology. 2003, Vol 61, Num 11, pp 1588-1594, 7 p ; ref : 34 ref
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Epidémiologie Evolution Facteur risque Homme Hypertonie spastique Incidence Myélopathie Paraparésie Pronostic Prévalence Virus HTLV Etats Unis Infection Moelle épinière pathologie Muscle strié pathologie Parésie Retroviridae Santé publique Système nerveux central pathologie Système nerveux pathologie Trouble moteur Trouble neurologique Trouble tonus Virose Virus Amérique du Nord Amérique
- Keyword (en)
- Epidemiology Evolution Risk factor Human Spasticity Incidence Myelopathy Paraparesia Prognosis Prevalence HTLV virus United States Infection Spinal cord disease Striated muscle disease Paresis Retroviridae Public health Central nervous system disease Nervous system diseases Motor system disorder Neurological disorder Muscle tonus alteration Viral disease Virus North America America
- Keyword (es)
- Epidemiología Evolución Factor riesgo Hombre Hipertonia espástica Incidencia Mielopatía Paraparesia Pronóstico Prevalencia HTLV virus Estados Unidos Infección Médula espinal patología Músculo estriado patología Paresia Retroviridae Salud pública Sistema nervosio central patología Sistema nervioso patología Trastorno motor Trastorno neurológico Trastorno tono muscular Virosis Virus America del norte America
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02A Viral diseases of the nervous system
- Discipline
- Infectious pathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15335683
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1212/01.WNL.0000096011.92542.DA 
https://dx.doi.org/10.1212/01.WNL.0000096011.92542.DA
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1212\/01.WNL.0000096011.92542.DA\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1588\";s:8:\"\u0000*\u0000epage\";s:4:\"1594\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ORLAND\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"ENGSTROM, J\";i:1;s:11:\"LOUGHLIN, K\";i:2;s:12:\"MURPHY, E. L\";i:3;s:9:\"FRIDEY, J\";i:4;s:12:\"SACHER, R. A\";i:5;s:11:\"SMITH, J. W\";i:6;s:7:\"NASS, C\";i:7;s:11:\"GARRATTY, G\";i:8;s:9:\"NEWMAN, B\";i:9;s:8:\"SMITH, D\";i:10;s:7:\"WANG, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1212\/01.WNL.0000096011.92542.DA\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1588\";s:8:\"\u0000*\u0000epage\";s:4:\"1594\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ORLAND\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"ENGSTROM, J\";i:1;s:11:\"LOUGHLIN, K\";i:2;s:12:\"MURPHY, E. L\";i:3;s:9:\"FRIDEY, J\";i:4;s:12:\"SACHER, R. A\";i:5;s:11:\"SMITH, J. W\";i:6;s:7:\"NASS, C\";i:7;s:11:\"GARRATTY, G\";i:8;s:9:\"NEWMAN, B\";i:9;s:8:\"SMITH, D\";i:10;s:7:\"WANG, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1212\/01.WNL.0000096011.92542.DA\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1212\/01.WNL.0000096011.92542.DA\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1588\";s:8:\"\u0000*\u0000epage\";s:4:\"1594\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ORLAND\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"ENGSTROM, J\";i:1;s:11:\"LOUGHLIN, K\";i:2;s:12:\"MURPHY, E. L\";i:3;s:9:\"FRIDEY, J\";i:4;s:12:\"SACHER, R. A\";i:5;s:11:\"SMITH, J. W\";i:6;s:7:\"NASS, C\";i:7;s:11:\"GARRATTY, G\";i:8;s:9:\"NEWMAN, B\";i:9;s:8:\"SMITH, D\";i:10;s:7:\"WANG, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1212\/01.WNL.0000096011.92542.DA\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1588\";s:8:\"\u0000*\u0000epage\";s:4:\"1594\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ORLAND\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"ENGSTROM, J\";i:1;s:11:\"LOUGHLIN, K\";i:2;s:12:\"MURPHY, E. L\";i:3;s:9:\"FRIDEY, J\";i:4;s:12:\"SACHER, R. A\";i:5;s:11:\"SMITH, J. W\";i:6;s:7:\"NASS, C\";i:7;s:11:\"GARRATTY, G\";i:8;s:9:\"NEWMAN, B\";i:9;s:8:\"SMITH, D\";i:10;s:7:\"WANG, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1212\/01.WNL.0000096011.92542.DA\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1588\";s:8:\"\u0000*\u0000epage\";s:4:\"1594\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ORLAND\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"ENGSTROM, J\";i:1;s:11:\"LOUGHLIN, K\";i:2;s:12:\"MURPHY, E. L\";i:3;s:9:\"FRIDEY, J\";i:4;s:12:\"SACHER, R. A\";i:5;s:11:\"SMITH, J. W\";i:6;s:7:\"NASS, C\";i:7;s:11:\"GARRATTY, G\";i:8;s:9:\"NEWMAN, B\";i:9;s:8:\"SMITH, D\";i:10;s:7:\"WANG, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
